Post Thu Mar 30, 2017 8:07 pm

2017-Zhou et al-Leukemia

"Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo"
Zhou H, Mak PY, Mu H, Mak DH, Zeng Z, Cortes J, Liu Q, Andreeff M, Carter BZ
Leukemia, 2017
http://dx.doi.org/10.1038/leu.2017.87